Phân tích
Phân tích chuyên sâu về thị trường dược, chuỗi cung ứng, công nghệ và quy định
#supply chain ×
Phân tích
30 thg 8, 2026•1 phút đọc
Domestic NOAC leader Rixiana faces supply strain ahead of November patent expiry
Rixiana (edoxaban) shows signs of supply pressure across all dosages as its Korean patent expires in November, prompting close monitoring of the market.
Phân tích
30 thg 8, 2026•1 phút đọc
Supply Prices of Hydrasexan Antidiarrheal Raised Effective July 1
Korean Aebot and Samjin Pharma have sharply increased the supply price of the pediatric and adult antidiarrheal Hydrasexan due to raw‑material costs and exchange‑rate shifts.